Kiniksa Pharmaceuticals trading halted, volatility trading pause

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on KNSA:

• Kiniksa sees FY24 ARCALYST revenue between $410M-$420M
• Kiniksa reports Q3 EPS (18c), consensus 3c
• Kiniksa partners with Carly Pearce in expansion of Life DisRPted campaign
• KNSA Earnings this Week: How Will it Perform?
• Kiniksa Pharmaceuticals Appoints New Board Member